Communicable diseases

Communicable diseases

Glycolytic Enzymes as Potential Vaccine Candidates for Streptococcus Pneumoniae

Streptococcus pneumoniae is a leading cause of various infectious diseases worldwide, including otitis media, sinusitis, pneumonia, bacteremia, and meningitis. Current vaccines are often limited by the number of capsular polysaccharides that can be included, making pneumococcal proteins an attractive alternative for vaccine candidates. Researchers in Israel have identified glycolytic enzymes

Communicable diseases

Nasopharyngeal vs. Oropharyngeal Sampling for Streptococcus and Haemophilus Isolation

The study highlights the importance of nasopharyngeal versus oropharyngeal sampling for isolating Streptococcus pneumoniae and Haemophilus influenzae from healthy and sick individuals, with the method of choice varying by age. The research, published in the Journal of Clinical Microbiology, found that nasopharyngeal (NP) sampling detected nearly 100% of Streptococcus pneumoniae

Communicable diseases

Rising Bacterial Infections Coincide with Increased HIV Seroprevalence in Northeastern Thailand

A recent study from Thailand reveals a striking correlation between the rise of bacterial infections and increased HIV seroprevalence in the northeastern region. Conducted between 1989 and 1998, the survey observed a notable increase in infections caused by certain pathogens, including Burkholderia pseudomallei, non-typhoid Salmonellae, and Cryptococcus neoformans, which were